Massachusetts Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Massachusetts Financial Services's IONS Position: Q3 2026 in Review
Massachusetts Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 4.6% in Q3 2026, selling an estimated $1.7M and leaving 621,923 shares worth $27.8M. The position accounts for 0.01% of the portfolio, ranked #581.
Massachusetts Financial Services first reported a position in IONS in Q1 2014 and has held it in 20 quarters since. The position peaked at $67.8M in Q4 2014. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Massachusetts Financial Services held 621,923 shares of Ionis Pharmaceuticals worth $27.8M as of Q3 2026.
- Massachusetts Financial Services sold 29,893 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.7M.
- Ionis Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #581 holding.
- Massachusetts Financial Services first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 20 quarters since.
- Massachusetts Financial Services's Ionis Pharmaceuticals position peaked at $67.8M in Q4 2014.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.